Am J Physiol Cell Physiol Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Am J Physiol Cell Physiol (October 30, 2003). doi:10.1152/ajpcell.00201.2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/3/C507    most recent
00201.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martin, K. A
Right arrow Articles by Powell, R. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, K. A
Right arrow Articles by Powell, R. J
Submitted on May 15, 2003
Accepted on October 20, 2003

The mTOR / p70 S6K1 pathway regulates vascular smooth muscle cell differentiation

Kathleen A Martin1*, Eva M Rzucidlo2, Bethany L Merenick1, Diane C Fingar3, David J Brown2, Robert J Wagner2, and Richard J Powell2

1 Department of Surgery, Dartmouth Medical School, Lebanon, NH, USA; Department of Pharmacology and Toxicology, Dartmouth Medical School, Lebanon, NH, USA
2 Department of Surgery, Dartmouth Medical School, Lebanon, NH, USA
3 Department of Cell Biology, Harvard Medical School, Boston, MA, USA

* To whom correspondence should be addressed. E-mail: Kathleen.A.Martin{at}Dartmouth.edu.

Vascular smooth muscle cells (VSMC) in mature, normal blood vessels exhibit a differentiated, quiescent, contractile morphology, but injury induces a phenotypic modulation toward a proliferative, de-differentiated, migratory phenotype with upregulated extracellular matrix protein synthesis (synthetic phenotype) which contributes to intimal hyperplasia. The mTOR pathway inhibitor rapamycin inhibits intimal hyperplasia in animal models and in human clinical trials. We report that rapamycin treatment induces differentiation in cultured synthetic phenotype VSMC from multiple species. VSMC treated with rapamycin assumed a contractile morphology, quantitatively reflected by a 67% decrease in cell area. Total protein and collagen synthesis were also inhibited by rapamycin. Rapamycin induced expression of the VSMC differentiation marker contractile proteins SM {alpha}-actin, calponin, and SM myosin heavy chain (SM-MHC), as observed by immunoblotting and immunohistochemistry. Notably, we detected a striking rapamycin induction of calponin and SM-MHC mRNA, suggesting a role for mTOR in transcriptional control of VSMC gene expression. Rapamycin also induced expression of the cyclin dependent kinase inhibitors p21cip and p27kip, consistent with cell cycle withdrawal. Rapamycin inhibits mTOR, a signaling protein that regulates protein synthesis effectors, including p70 S6K1. Overexpression of p70 S6K1 inhibited rapamycin-induced contractile protein and p21cip expression, suggesting that this kinase opposes VSMC differentiation. In conclusion, we report that regulation of VSMC differentiation is a novel function of the rapamycin-sensitive mTOR signaling pathway.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
W. Jiang, Z. Zhu, and H. J. Thompson
Dietary Energy Restriction Modulates the Activity of AMP-Activated Protein Kinase, Akt, and Mammalian Target of Rapamycin in Mammary Carcinomas, Mammary Gland, and Liver
Cancer Res., July 1, 2008; 68(13): 5492 - 5499.
[Abstract] [Full Text] [PDF]

Home page
 Exp PhysiolHome page
K. M. Rice, D. H. Desai, D. L. Preston, P. S. Wehner, and E. R. Blough
Vascular: Uniaxial stretch-induced regulation of mitogen-activated protein kinase, Akt and p70 S6 kinase in the ageing Fischer 344 x Brown Norway rat aorta
Exp Physiol, September 1, 2007; 92(5): 963 - 970.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
S. Albinsson and P. Hellstrand
Integration of signal pathways for stretch-dependent growth and differentiation in vascular smooth muscle
Am J Physiol Cell Physiol, August 1, 2007; 293(2): C772 - C782.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
D. K. Bowles, K. K. Maddali, V. C. Dhulipala, and D. H. Korzick
PKC{delta} mediates anti-proliferative, pro-apoptic effects of testosterone on coronary smooth muscle
Am J Physiol Cell Physiol, August 1, 2007; 293(2): C805 - C813.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
K. L. Ma, X. Z. Ruan, S. H. Powis, J. F. Moorhead, and Z. Varghese
Anti-atherosclerotic effects of sirolimus on human vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2721 - H2728.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. Verheye, W. Martinet, M. M. Kockx, M. W.M. Knaapen, K. Salu, J.-P. Timmermans, J. T. Ellis, D. L. Kilpatrick, and G. R.Y. De Meyer
Selective Clearance of Macrophages in Atherosclerotic Plaques by Autophagy
J. Am. Coll. Cardiol., February 13, 2007; 49(6): 706 - 715.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
H. R. Lock, S. H. Sacks, and M. G. Robson
Rapamycin at subimmunosuppressive levels inhibits mesangial cell proliferation and extracellular matrix production
Am J Physiol Renal Physiol, January 1, 2007; 292(1): F76 - F81.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
E. Grantcharova, H. P. Reusch, S. Grossmann, J. Eichhorst, H.-W. Krell, M. Beyermann, W. Rosenthal, and A. Oksche
N-Terminal Proteolysis of the Endothelin B Receptor Abolishes Its Ability to Induce EGF Receptor Transactivation and Contractile Protein Expression in Vascular Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1288 - 1296.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
K. M. Fetalvero, M. Shyu, A. P. Nomikos, Y.-F. Chiu, R. J. Wagner, R. J. Powell, J. Hwa, and K. A. Martin
The prostacyclin receptor induces human vascular smooth muscle cell differentiation via the protein kinase A pathway
Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1337 - H1346.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
D. Rosner, N. McCarthy, and M. Bennett
Rapamycin inhibits human in stent restenosis vascular smooth muscle cells independently of pRB phosphorylation and p53
Cardiovasc Res, June 1, 2005; 66(3): 601 - 610.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. H. Damon
Sympathetic innervation promotes vascular smooth muscle differentiation
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2785 - H2791.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
K. Sakakibara, B. Liu, S. Hollenbeck, and K. C. Kent
Rapamycin inhibits fibronectin-induced migration of the human arterial smooth muscle line (E47) through the mammalian target of rapamycin
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2861 - H2868.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. A. Costa and D. I. Simon
Molecular Basis of Restenosis and Drug-Eluting Stents
Circulation, May 3, 2005; 111(17): 2257 - 2273.
[Full Text] [PDF]

Home page
 Circ. Res.Home page
D. Bi, J. Nishimura, N. Niiro, K. Hirano, and H. Kanaide
Contractile Properties of the Cultured Vascular Smooth Muscle Cells: The Crucial Role Played by RhoA in the Regulation of Contractility
Circ. Res., April 29, 2005; 96(8): 890 - 897.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
P. A. Lucchesi
Rapamycin plays a new role as differentiator of vascular smooth muscle phenotype. Focus on "The mTOR/p70 S6K1 pathway regulates vascular smooth muscle differentiation"
Am J Physiol Cell Physiol, March 1, 2004; 286(3): C480 - C481.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1976 by the American Physiological Society.